Relationship between diabetes mellitus and SARS-CoV-2 infection in patients with SARS hospitalized in the city of Cascavel-PR in 2020




COVID-19; Diabetes; SARS-CoV-2; Pandemia; SRAG.


COVID-19 is a relatively new infectious disease that had numerous victims spread around the world during the year 2020. The rates of complications and mortality from the disease are higher in people who already have comorbidities, one of the most discussed and known is Diabetes. Mellitus. This study aims to collect data from the Municipal Health Department of the city of Cascavel-PR of all patients who contracted SARS-CoV-2 and progressed to Severe Acute Respiratory Syndrome (SARS) in 2020, in order to compare the number of patients, average length of stay and mortality rate of two groups of patients who contracted the infection and diagnosed with SARS: one group with pre-existing diabetes and the other without the disease. For this, a quantitative methodology will be used, of the descriptive type, analyzing the data obtained and presenting them in graphs in an explanatory and descriptive way. The research pointed out as main results that adults, between 41-80 years old were the most affected by COVID-19, in addition to that patients who had diabetes had a higher incidence of death when hospitalized in ICUs, compared to those who did not diabetics.


Brito, S. B., Braga, I. O., Moraes, M. M., Cunha, C. C., Leão, S. C., & Takenami, I. (13 de Novembro de 2020). Mecanismos imunopatológicos envolvidos na infecção por SARS-CoV-2. Jornal Brasileiro de Patologia e Medicina Laboratorial(56), 148-149.

Casarin, S. T., Porto, A. R., Gabatz, R. I., Bonow, C. A., Ribeiro, J. P., & Mota, M. S. (2020). Tipos de revisão de literatura: considerações das editoras do Journal of Nursing and Health. ournal of Nursing and Health, 1-7. Fonte:

Castro, R. M., Silva, A. M., Silva, A. K., Araújo, B. F., Maluf, B. V., & Franco, J. C. (2021). Diabetes mellitus e suas complicações - uma revisão sistemática e informativa. Brazilian Journal of Health Review, 4(1), 3349-3391.

Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., . . . Jüni, P. (Janeiro de 2020). 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. European Heart Journal., 41(2). doi:10.1093/eurheartj/ehz486

Cuschieri, S., & Grech, S. (2020). COVID-19 and diabetes: The why, the what and the how. Journal of Diabetes and its Complications, 34(9), 1-5.

Dell’Era, V., Filippo, F., Garzaro, G., Gatto, M., Valletti, P. A., & Garzaro, M. (11 de Junho de 2020). Smell and taste disorders during COVID‐19 outbreak: A cross‐sectional study on 355 patients. Head & Neck(42), 1591-1596.

Feitosa, A. (Setembro-Dezembro de 2020). Diabetes e COVID-19. Revista Científica Hospital Santa Isabel, 3/4(4), 139-149.

Fontelles, M. J., Simões, M. G., Farias, S. H., & Fontelles, R. G. (2009). Metodologia da pesquisa científica: diretrizes para a elaboração de um protocolo de pesquisa. Revista Paraense de Medicina, 23(3), 1-8. Fonte:

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., . . . Xie, J. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223), 497-506.

Kronenberg, H. M., Melmed, S., Polonsky, K. S., & Larsen, P. R. (2010). Williams Tratado de Endocrinologia (11ª ed., Vol. 1). Rio de Janeiro, Rio de Janeiro, Brasil: Elsevier.

Lacobellis, G. (2020). COVID-19 and diabetes: Can DPP4 inhibition play a role? Diabetes Research and Clinical Practice, 1-2.

Ministério da Saúde. (2006). Cadernos de Atenção Básica: Diabetes Mellitus. Brasilia.

Ministério da Saúde. (2021). Guia de vigilância epidemiológica : emergência de saúde pública de importância nacional pela doença pelo coronavírus 2019 - COVID-19 (1 ed.). Brasilia, Distrito Federal, Brasil: Ministério da Saúde. Fonte:

Ministério da Saúde. (30 de Dezembro de 2021). Diabetes (diabetes mellitus). Fonte: Diabetes (diabetes mellitus):

Peric, S., & Stulnig, T. M. (2020). Diabetes and COVID-19. Wiener klinische Wochenschrift, 132, 356-361.

Remuzzi, A., & Remuzzi, G. (2020). COVID-19 and Italy: what next? The Lancet, 1225-1228.

Sociedade Brasileira de Diabetes. (2019). Diretrizes Sociedade Brasileira de Diabetes 2019-2020. São Paulo: Clannad. Fonte:

Sociedade Brasileira de Diabetes. (2019). Sociedade Brasileira de Diabetes. Fonte: Sociedade Brasileira de Diabetes:

Sociedade Brasileira de Endocrinologia e Metabologia. (15 de Abril de 2021). Fonte: Números do Diabetes no Brasil:

Vilar, L. (2013). Endocrinologia Clinica (5 ed., Vol. 1). (L. Vilar, Ed.) Rio de Janeiro, Rio de Janeiro, Brasil: Guanabara Koogan.

World Health Organization. (10 de Novembro de 2021). Diabetes. Fonte: WHO: Health Topics:

Xavier, A. R., Silva, J. S., Almeida, J. P., Conceição, J. F., Lacerda, G. S., & Kanaan, S. (2020). COVID-19: manifestações clínicas e laboratoriais na infecção pelo novo coronavírus. Jornal Brasileiro de Patologia e Medicina Laboratorial, 1-9.

Zhou, F., Yu, T., Du, R., Fan, G., Li, Y., Liu, Z., . . . Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 1054-1062.



How to Cite

SILVA, L. C. A. da; PESCADOR , M. V. B. Relationship between diabetes mellitus and SARS-CoV-2 infection in patients with SARS hospitalized in the city of Cascavel-PR in 2020. Research, Society and Development, [S. l.], v. 11, n. 9, p. e8711931136, 2022. DOI: 10.33448/rsd-v11i9.31136. Disponível em: Acesso em: 27 sep. 2022.



Health Sciences